Literature DB >> 6594766

Opportunistic Scopulariopsis pneumonia in an immunocompromised host.

L J Wheat, M Bartlett, M Ciccarelli, J W Smith.   

Abstract

We have described a patient with fatal Scopulariopsis pneumonia, a previously unreported infection, complicating immunosuppressive therapy for acute myeloblastic leukemia. This Scopulariopsis isolate was highly resistant to available antifungal agents, in part accounting for our patient's death.

Entities:  

Mesh：

Year:  1984        PMID： 6594766     DOI： 10.1097/00007611-198412000-00041

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  8 in total

1.  In vitro antifungal susceptibilities of Scopulariopsis isolates.

Authors:  C Aguilar; I Pujol; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; Annette W Fothergill; Josep Cano-Lira; Josepa Gené; C A Decock; G S de Hoog; Josep Guarro
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

4.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 5.  The importance of genomic variation for biodiversity, ecosystems and people.

Authors:  Madlen Stange; Rowan D H Barrett; Andrew P Hendry
Journal:  Nat Rev Genet       Date:  2020-10-16       Impact factor: 53.242

6.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Authors:  Limin Yao; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

7.  Disseminated Microascus cirrosus infection in pediatric bone marrow transplant recipient.

Authors:  K K Krisher; N B Holdridge; M M Mustafa; M G Rinaldi; D A McGough
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 8.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.